WJ460

CAS No. 1415251-36-3

WJ460 ( —— )

Catalog No. M26864 CAS No. 1415251-36-3

WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 129 Get Quote
10MG 219 Get Quote
25MG 357 Get Quote
50MG 537 Get Quote
100MG 781 Get Quote
500MG 1593 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    WJ460
  • Note
    Research use only, not for human use.
  • Brief Description
    WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.
  • Description
    WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.(In Vitro):WJ460 dose-dependently blocks breast cancer cell invasion through Collagen I(IC50: 43.37?nM in MDA-MB-231 and 36.40 nM in BT549 cells).(In Vivo):In a spontaneous metastasis model, WJ460 inhibits angiogenesis, breast tumor growth, and spontaneous metastasis .
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Adrenocorticotropic hormone (ACTH)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1415251-36-3
  • Formula Weight
    460.6
  • Molecular Formula
    C27H28N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NCCCCC=1C=CC=CC1)C2=CC=CC(=C2)C3SCC(=O)N3C=4C=CC=CC4OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Francesco Iuliano, et al. Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation.
molnova catalog
related products
  • Scutebarbatine B

    Scutebarbatine B shows weak cytotoxicity with IC50 values ranging from 35.11 to 42.73 μM against K562 cell lines and HL60 cell lines.

  • Rilmenidine Phosphat...

    Rilmenidine Phosphate is a selective I(1) imidazoline receptor agonist, used to treat hypertension.

  • DSR-6434

    DSR-6434 has a strong antitumor effect. DSR-6434 is a potent and selective Toll-like receptor 7 (TLR7) agonist, with EC50s of 7.2 nM and 4.6 nM for human and mice TLR7, respectively.